US Broker Ratings

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 3.27% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, finds itself at an intriguing juncture, presenting both challenges and opportunities for potential investors. Based in Charlotte, North Carolina,..

MiMedx Group, Inc. (MDXG) Stock Analysis: A Promising 72% Upside in the Biotech Space

MiMedx Group, Inc. (NASDAQ: MDXG), a notable player in the biotechnology sector, has been attracting attention with its innovative healthcare solutions. Specializing in the development and distribution of placental tissue..

SpringWorks Therapeutics, Inc. (SWTX): Investor Outlook Highlights Revenue Growth and Market Position

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) has been making waves in the biotechnology sector with its focused approach on developing treatments for rare diseases and cancer. With a current market capitalization..

Haemonetics Corporation (HAE) Stock Analysis: A 42% Upside Potential in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, stands at a pivotal point for investors seeking robust growth in the medical devices industry. With a current market..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with 8.78% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the U.S. healthcare sector, operates as a prominent provider of senior living solutions. Specializing in Independent Living, Assisted Living and..

Novavax, Inc. (NVAX) Stock Analysis: Exploring Its 70.97% Potential Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to vaccine development. Based in Gaithersburg, Maryland, Novavax is..

Merus N.V. (MRUS) Stock Analysis: A Biotech with 37.47% Potential Upside

Merus N.V. (NASDAQ: MRUS), a Dutch clinical-stage biotechnology company, is capturing investor attention with its promising pipeline of antibody therapeutics and a significant potential upside of 37.47%. As a key..

Evotec SE (EVO) Stock Analysis: Uncovering a 60% Potential Upside Amidst Innovative Collaborations

Investors with a keen eye on the healthcare sector may want to consider Evotec SE (EVO), a promising player in the drug discovery and development landscape. With its headquarters in..

MannKind Corporation (MNKD) Stock Analysis: A 149% Upside and Strong Buy Ratings Propel Investor Interest

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, has become a focal point for investors due to its robust potential upside and unanimous buy ratings from analysts...

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Healthcare Innovator with 7.35% Potential Upside

LeMaitre Vascular, Inc. (LMAT) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Burlington, Massachusetts, this company has carved a niche..

GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 23% Potential Upside in the Diagnostics Sector

For investors keen on the healthcare sector, particularly within diagnostics and research, GRAIL, Inc. (NASDAQ: GRAL) offers a compelling proposition. With its current price standing at $32.925 and a potential..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unveiling the 99.82% Upside Potential

Investors with an eye on the biotechnology sector might find Travere Therapeutics, Inc. (NASDAQ: TVTX) an intriguing opportunity, especially given the company’s potential upside of nearly 100%. With a focus..

Immunocore Holdings plc (IMCR) Stock Analysis: Unveiling a Potential 90% Upside in Groundbreaking Biotech Innovations

Immunocore Holdings plc (NASDAQ: IMCR), a trailblazer in the biotechnology sector, is captivating investor attention with its innovative approach to immunotherapy and a potential upside of 90.84%. As a commercial-stage..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Exploring a 14% Potential Upside with Innovative Pain Management Solutions

For investors eyeing opportunities in the healthcare sector, Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case with its current market positioning and innovative product lineup. With a market capitalization..

Omnicell, Inc. (OMCL) Stock Analysis: Promising 32.97% Upside Potential Ignites Investor Interest

Omnicell, Inc. (NASDAQ: OMCL), a stalwart in the healthcare sector, particularly in health information services, has been capturing investor interest with its robust potential for growth. With a current market..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Potential 129% Upside in the Biotech Sector

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a burgeoning player in the biotechnology sector, is drawing significant attention from investors with its promising pipeline and impressive potential upside. With a market capitalization..

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Powerhouse with 135% Potential Upside

CG Oncology, Inc. (NASDAQ: CGON) is increasingly capturing the attention of investors within the biotechnology sector, particularly due to its promising pipeline in bladder cancer therapeutics. With a market capitalization..

Amedisys Inc (AMED) Investor Outlook: Insights into Healthcare’s Home Care Leader

Amedisys Inc (NASDAQ: AMED) stands as a key player in the U.S. healthcare sector, specializing in home health, hospice, and high acuity care. With a market capitalization of $3.32 billion,..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating Growth in a Competitive Healthcare Sector with a 26% Upside Potential

Investors with an eye on the healthcare sector should take a closer look at GoodRx Holdings, Inc. (NASDAQ: GDRX), a company that has carved out a niche in health information..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth Potential in the Dental Market

Envista Holdings Corporation (NVST) presents an intriguing opportunity for investors eyeing the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $3.51 billion, Envista..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds